Template:PID antibiotics: Difference between revisions

(Convert to AntibioticDose with disease=Pelvic inflammatory disease for SMW linking)
(Add AntibioticDose entries: Azithromycin)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
===Antibiotics===
===Antibiotics===
*No sexual activity for 2 weeks;  
*No sexual activity for 2 weeks;
*Treat all partners who had sex with patient during previous 60 days prior to symptom onset
*Treat all partners who had sex with patient during previous 60 days prior to symptom onset
==== Outpatient Antibiotic Options ====
==== Outpatient Antibiotic Options ====
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Ceftriaxone|dose=500mg IM x1 (1g if over 150kg)|context=Outpatient|population=Adult}}<ref>Hayes BD. Trick of the Trade: IV ceftriaxone for gonorrhea. October 9th, 2012 ALiEM. https://www.aliem.com/2012/10/trick-of-trade-iv-ceftriaxone-for/. Accessed October 23, 2018.</ref><ref>Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020 https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm</ref> x1 + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Doxycycline|dose=100mg PO BID x 14 days|context=Outpatient|population=Adult}} + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Metronidazole|dose=500mg PO BID x 14 days|context=Outpatient|population=Adult}} <ref>Ness RB et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002;186:929–37</ref><ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Ceftriaxone|dose=500mg IM x1 (1g if >150kg)|context=Outpatient; combined with Doxycycline and Metronidazole}}<ref>Hayes BD. Trick of the Trade: IV ceftriaxone for gonorrhea. October 9th, 2012 ALiEM. https://www.aliem.com/2012/10/trick-of-trade-iv-ceftriaxone-for/. Accessed October 23, 2018.</ref><ref>Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020 https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm</ref> + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Doxycycline|dose=100mg PO BID x 14 days|context=Outpatient}} + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Metronidazole|dose=500mg PO BID x 14 days|context=Outpatient; recommended empirically by CDC and European guidelines}}<ref>Ness RB et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002;186:929-37</ref><ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1-187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>
**[[Metronidazole]]
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Cefoxitin|dose=2g IM x1 plus Probenecid 1g PO|context=Outpatient alternative}}<ref>CDC PID Treatment http://www.cdc.gov/std/treatment/2010/pid.htm</ref> + [[Doxycycline]] 100mg PO BID x 14 days + [[metronidazole]]
***Recommended for empiric treatment of PID by the CDC <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>
***Recommended empirically by European guidelines <ref>Ross J, Guaschino S, Cusini M, Jensen J, 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018 Feb;29(2):108-114. doi: 10.1177/0956462417744099. Epub 2017 Dec 4.</ref>
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Cefoxitin|dose=2g IM x1 with Probenecid 1g PO x1|context=Alt outpatient|population=Adult}}<ref>CDC PID Treatment http://www.cdc.gov/std/treatment/2010/pid.htm</ref> + [[Doxycycline]] 100mg PO BID x 14 days + [[Metronidazole]]
 
==== Inpatient Antibiotic Options ====
==== Inpatient Antibiotic Options ====
*Recommended<ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>: {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Ceftriaxone|dose=1g IV q24hrs|context=Inpatient|population=Adult}} OR {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Cefoxitin|dose=2g IV q6hrs|context=Inpatient|population=Adult}} OR {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Cefotetan|dose=2g IV q12hrs|context=Inpatient|population=Adult}}) + [[Doxycycline]] 100mg PO or IV q12hrs + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Metronidazole|dose=500mg IV or PO q12hrs|context=Inpatient|population=Adult}} OR
*Recommended<ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1-187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>: {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Ceftriaxone|dose=1g IV q24hr|context=Inpatient; combined with Doxycycline and Metronidazole}} OR {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Cefoxitin|dose=2g IV q6hr|context=Inpatient}} OR {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Cefotetan|dose=2g IV q12hr|context=Inpatient}} + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Doxycycline|dose=100mg PO or IV q12hr|context=Inpatient}} + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Metronidazole|dose=500mg IV or PO q12hr|context=Inpatient}} OR
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Clindamycin|dose=900mg IV q8hrs|context=Inpatient alt|population=Adult}} + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Gentamicin|dose=2mg/kg loading then 1.5mg/kg q8hrs IV|context=Inpatient alt with Clindamycin|population=Adult}} OR
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Clindamycin|dose=900mg IV q8hr|context=Inpatient alternative; combined with Gentamicin}} + {{AntibioticDose|disease=Pelvic inflammatory disease|drug=Gentamicin|dose=2mg/kg loading then 1.5mg/kg q8hr IV|context=Inpatient; combined with Clindamycin}} OR
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Ampicillin/Sulbactam|dose=3g IV q6hrs|context=Inpatient alt|population=Adult}} + [[Doxycycline]] 100mg IV/PO q12hrs
*{{AntibioticDose|disease=Pelvic inflammatory disease|drug=Ampicillin/Sulbactam|dose=3g IV q6hr|context=Inpatient alternative; combined with Doxycycline}} + [[doxycycline]] 100mg IV/PO q12hr
*{{AntibioticDose|drug=Azithromycin|dose=500mg IV q24h x1-2 days, then 250mg PO q24h x5-6 days|context=PID|disease=Pelvic inflammatory disease|population=Adult}}

Latest revision as of 10:54, 20 March 2026

Antibiotics

  • No sexual activity for 2 weeks;
  • Treat all partners who had sex with patient during previous 60 days prior to symptom onset

Outpatient Antibiotic Options

Inpatient Antibiotic Options

  1. ↑ Hayes BD. Trick of the Trade: IV ceftriaxone for gonorrhea. October 9th, 2012 ALiEM. https://www.aliem.com/2012/10/trick-of-trade-iv-ceftriaxone-for/. Accessed October 23, 2018.
  2. ↑ Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020 https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm
  3. ↑ Ness RB et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002;186:929-37
  4. ↑ Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1-187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  5. ↑ CDC PID Treatment http://www.cdc.gov/std/treatment/2010/pid.htm
  6. ↑ Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1-187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
Retrieved from "https://www.wikem.org/w/index.php?title=Template:PID_antibiotics&oldid=386658"